Palo Alto Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-21,883
Closed -$2.17M 39
2019
Q3
$2.17M Sell
21,883
-85,000
-80% -$8.08M 0.14% 27
2019
Q2
$9.88M Sell
106,883
-159,450
-60% -$15.1M 0.48% 27
2019
Q1
$25.1M Sell
266,333
-266,334
-50% -$23.3M 1.05% 23
2018
Q4
$34.1M Buy
532,667
+103,400
+24% +$7.63M 1.82% 16
2018
Q3
$38.4M Buy
429,267
+34,427
+9% +$3.04M 1.55% 18
2018
Q2
$31.4M Buy
394,840
+15,700
+4% +$1.3M 1.25% 20
2018
Q1
$33.8M Buy
379,140
+71,200
+23% +$6.84M 1.45% 20
2017
Q4
$32.1M Buy
307,940
+12,700
+4% +$1.43M 1.38% 20
2017
Q3
$43.1M Hold
295,240
1.81% 16
2017
Q2
$38.3M Hold
295,240
1.79% 15
2017
Q1
$36.7M Hold
295,240
1.74% 17
2016
Q4
$34.2M Buy
295,240
+2,540
+0.9% +$283K 1.95% 16
2016
Q3
$30.6M Buy
292,700
+13,100
+5% +$1.42M 1.78% 17
2016
Q2
$27.6M Buy
279,600
+8,800
+3% +$910K 2.08% 14
2016
Q1
$27.1M Hold
270,800
2.1% 15
2015
Q4
$32.4M Hold
270,800
1.81% 16
2015
Q3
$29.3M Buy
270,800
+8,600
+3% +$1.07M 1.41% 15
2015
Q2
$30.3M Buy
262,200
+12,800
+5% +$1.46M 1.35% 18
2015
Q1
$28.8M Buy
249,400
+33,900
+16% +$4.05M 1.42% 15
2014
Q4
$24.1M Buy
215,500
+43,900
+26% +$4.63M 1.42% 17
2014
Q3
$16.3M Buy
171,600
+16,420
+11% +$1.48M 1.22% 21
2014
Q2
$13.3M Buy
155,180
+150,000
+2,896% +$11.4M 0.99% 24
2014
Q1
$362K Hold
5,180
0.03% 37
2013
Q4
$438K Buy
5,180
+1,800
+53% +$142K 0.04% 34
2013
Q3
$260K Buy
+3,380
New +$237K 0.03% 32

Other funds holding CELG

Palo Alto Investors's CELG Position: Q4 2019 in Review

Palo Alto Investors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 21,883 shares — an estimated $2.17M sold.

Palo Alto Investors first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $43.1M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Palo Alto Investors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Palo Alto Investors sold 21,883 Celgene Corp shares in Q4 2019, an estimated $2.17M.
  • Palo Alto Investors first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
  • Palo Alto Investors's Celgene Corp position peaked at $43.1M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Palo Alto Investors's 13F filing for Q4 2019, filed 14 Feb 2020.